Retension Pharmaceuticals Appoints Robert Wong as Chief Accounting Officer
Position
Chief Accounting Officer
Company
Retension Pharmaceuticals
McleanBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
On October 21, 2026, Retension Pharmaceuticals appointed Robert Wong as Vice President, Chief Accounting Officer, effective November 2, 2026. Mr. Wong brings 30 years of management and controllership experience to the role
Quick answer
Retension Pharmaceuticals Appoints Robert Wong as Chief Accounting Officer (October 23, 2026). Retension Pharmaceuticals is based in Mclean, Virginia, United States.
- Who is the new Chief Accounting Officer at Retension Pharmaceuticals?
- Retension Pharmaceuticals named Robert Wong Chief Accounting Officer, announced October 23, 2026.
- What did Retension Pharmaceuticals announce on October 23, 2026?
- On October 21, 2026, Retension Pharmaceuticals appointed Robert Wong as Vice President, Chief Accounting Officer, effective November 2, 2026.
- Where did Robert Wong work before joining Retension Pharmaceuticals?
- Robert Wong joins from The Save Mart Companies.
- What does Retension Pharmaceuticals do?
- Retension Pharmaceuticals is developing RTN-001, a differentiated, tissue-targeted PDE5 inhibitor that has been optimized for the treatment of uncontrolled hypertension.
- Where is Retension Pharmaceuticals based?
- Retension Pharmaceuticals is based in Mclean, Virginia, United States.
- Which similar companies made leadership changes around the same time?
- AbbVie Inc. (November 2, 2026), Os Therapies (October 1, 2026), Aquestive Therapeutics, Inc. (September 29, 2026) and Acadia Pharmaceuticals (October 23, 2026) also announced leadership changes within 45 days of Retension Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- AbbVie Director Resigns Following CEO Appointment at Align Technology (November 2, 2026)
- OS Therapies Appoints Mr. Clem as Chief Commercial Officer and Mr. Knuettel as Chief Financial Officer (October 1, 2026)
- Richard J. Daly Appointed as Director of Aquestive Therapeutics (September 29, 2026)
- Acadia Pharmaceuticals Announces Departure of Elizabeth H.Z. Thompson, Ph.D. (October 23, 2026)
- Gyre Therapeutics Appoints Ying Luo as CEO and Thomas Eastling as CFO (October 22, 2026)
- Cantargia AB Appoints Monic Stuart as Chief Medical Officer (October 26, 2026)
Who to call at Retension Pharmaceuticals, and when
A new leader at Retension Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Retension Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Retension Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Retension Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Retension Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Retension Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.